‘Tip of the iceberg’: Novartis-partnered UC Berkeley lab churns out a startup to tackle protein degradation

For the past decade, Daniel Nomura’s lab at UC Berkeley has been working to find chemical approaches to drug the so-called “undruggable,” and with the help of Novartis’ research arm for the past five years, he has built out the foundation for a new biotech in the protein stabilization field.


Click to view original post